148 related articles for article (PubMed ID: 8061431)
1. Enhanced tumor detection in the presence of fatty liver disease: cell-specific contrast agents.
Kreft BP; Tanimoto A; Baba Y; Zhao L; Finn JP; Stark DD
J Magn Reson Imaging; 1994; 4(3):337-42. PubMed ID: 8061431
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of tumor-liver contrast-to-noise ratio with gadobenate dimeglumine in MR imaging of rats.
Kreft BP; Tanimoto A; Stark DD; Baba Y; Zhao L; Chen JT; Compton CC; Finn JP; Cavagna FM
J Magn Reson Imaging; 1993; 3(1):41-9. PubMed ID: 8428100
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of hepatocyte-specific paramagnetic contrast media for MR imaging of hepatitis.
Tanimoto A; Kreft BP; Baba Y; Zhao L; Finn JP; Compton CC; Stark DD
J Magn Reson Imaging; 1993; 3(5):786-93. PubMed ID: 8400566
[TBL] [Abstract][Full Text] [Related]
4. Prolonged positive contrast enhancement with Gd-EOB-DTPA in experimental liver tumors: potential value in tissue characterization.
Ni Y; Marchal G; Yu J; Mühler A; Lukito G; Baert AL
J Magn Reson Imaging; 1994; 4(3):355-63. PubMed ID: 8061434
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of fatty liver with MR imaging.
Kreft BP; Tanimoto A; Baba Y; Zhao L; Chen J; Middleton MS; Compton CC; Finn JP; Stark DD
J Magn Reson Imaging; 1992; 2(4):463-71. PubMed ID: 1633400
[TBL] [Abstract][Full Text] [Related]
6. Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology.
Marchal G; Zhang X; Ni Y; Van Hecke P; Yu J; Baert AL
Magn Reson Imaging; 1993; 11(5):665-74. PubMed ID: 8345781
[TBL] [Abstract][Full Text] [Related]
7. Gadobenate dimeglumine as an intrabiliary contrast agent: comparison with mangafodipir trisodium with respect to non-dilated biliary tree depiction.
Lim JS; Kim MJ; Jung YY; Kim KW
Korean J Radiol; 2005; 6(4):229-34. PubMed ID: 16374080
[TBL] [Abstract][Full Text] [Related]
8. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
Seale MK; Catalano OA; Saini S; Hahn PF; Sahani DV
Radiographics; 2009 Oct; 29(6):1725-48. PubMed ID: 19959518
[TBL] [Abstract][Full Text] [Related]
9. Manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate): clinical experience with a new contrast agent.
Rofsky NM; Weinreb JC
Magn Reson Q; 1992 Sep; 8(3):156-68. PubMed ID: 1390058
[TBL] [Abstract][Full Text] [Related]
10. Multinodular focal fatty infiltration of the liver: atypical imaging findings on delayed T1-weighted Gd-BOPTA-enhanced liver-specific MR images.
Marin D; Iannaccone R; Catalano C; Passariello R
J Magn Reson Imaging; 2006 Sep; 24(3):690-4. PubMed ID: 16878304
[TBL] [Abstract][Full Text] [Related]
11. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
Reimer P; Schneider G; Schima W
Eur Radiol; 2004 Apr; 14(4):559-78. PubMed ID: 14986050
[TBL] [Abstract][Full Text] [Related]
12. Detectability of small liver metastases with gadolinium BOPTA.
Runge VM; Lee C; Williams NM
Invest Radiol; 1997 Sep; 32(9):557-65. PubMed ID: 9291044
[TBL] [Abstract][Full Text] [Related]
13. Experimental liver cancers: Mn-DPDP-enhanced rims in MR-microangiographic-histologic correlation study.
Ni Y; Marchal G; Yu J; Rummeny E; Zhang X; Lodemann KP; Baert AL
Radiology; 1993 Jul; 188(1):45-51. PubMed ID: 8390071
[TBL] [Abstract][Full Text] [Related]
14. Comparison of contrast enhanced CT and Mn-DPDP enhanced MRI for detection of focal hepatic lesions. Initial findings.
Birnbaum BA; Weinreb JC; Fernandez MP; Brown JJ; Rofsky NM; Young SW
Clin Imaging; 1994; 18(1):21-7. PubMed ID: 8180855
[TBL] [Abstract][Full Text] [Related]
15. Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.
Hamm B; Vogl TJ; Branding G; Schnell B; Taupitz M; Wolf KJ; Lissner J
Radiology; 1992 Jan; 182(1):167-74. PubMed ID: 1309218
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).
Murakami T; Baron RL; Peterson MS; Oliver JH; Davis PL; Confer SR; Federle MP
Radiology; 1996 Jul; 200(1):69-77. PubMed ID: 8657947
[TBL] [Abstract][Full Text] [Related]
17. The uptake of manganese dipyridoxal-diphosphate by chemically induced hepatocellular carcinoma in rats. A correlation between contrast-media-enhanced magnetic resonance imaging, tumor differentiation, and vascularization.
Ni Y; Marchal G; Zhang X; Van Hecke P; Michiels J; Yu J; Rummeny E; Lodemann KP; Baert AL
Invest Radiol; 1993 Jun; 28(6):520-8. PubMed ID: 8320070
[TBL] [Abstract][Full Text] [Related]
18. Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP).
Murakami T; Baron RL; Federle MP; Peterson MS; Oliver JH; Davis PL; Confer SR
Radiology; 1996 Feb; 198(2):567-72. PubMed ID: 8596867
[TBL] [Abstract][Full Text] [Related]
19. Soluble-type hepatobiliary contrast agents for MR imaging.
de Haën C; Gozzini L
J Magn Reson Imaging; 1993; 3(1):179-86. PubMed ID: 8428085
[No Abstract] [Full Text] [Related]
20. Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings.
Grazioli L; Morana G; Caudana R; Benetti A; Portolani N; Talamini G; Colombari R; Pirovano G; Kirchin MA; Spinazzi A
Invest Radiol; 2000 Jan; 35(1):25-34. PubMed ID: 10639033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]